Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000413184 | SCV000490500 | pathogenic | not provided | 2015-04-01 | criteria provided, single submitter | clinical testing | The p.E2059G pathogenic variant in the COL7A1 gene has been reported previously both as a homozygous variant and as a compound heterozygous variant with a different pathogenic variant in the COL7A1 gene (Kern et al. 2006) supporting its designation as a pathogenic variant. The p.E2059G variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. p.E2059G is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across class. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function, however amino acid substitutions in the triple helical domain are usually pathogenic. Missense variant in nearby residues (G2058A, G2061E, R2063W) have been reported in the Human Gene Mutation Database in association with DEB (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret p.E2059G as a pathogenic variant. |